Pesquisar
Nutriband Inc
NTRBAdicionar à lista de desejos
3.090USD
-0.100-3.13%
Fechamento 07/01, 16:00（ET）Cotações atrasadas em 15 min
37.56MValor de mercado
PerdaP/L TTM
Mais detalhes de Nutriband Inc Empresa
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Informações de Nutriband Inc
Código da empresaNTRB
Nome da EmpresaNutriband Inc
Data de listagemJun 20, 2017
CEOMelnik (Serguei)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 20
Endereço121 S Orange Ave Ste 1500
CidadeORLANDO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32801-3241
Telefone14073776695
Sitehttps://nutriband.com/
Código da empresaNTRB
Data de listagemJun 20, 2017
CEOMelnik (Serguei)
Executivos da empresa Nutriband Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Perguntas frequentes
Quem são os cinco principais acionistas de Nutriband Inc?
Os cinco principais acionistas de Nutriband Inc são: Mr. Serguei Melnik
Quantas instituições possuem ações da Nutriband Inc (NTRB)?
Em 2026Q1, 45 instituições possuíam ações da Nutriband Inc, com valor de mercado aproximado de 579.57K, representando 4.77% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 106153.00.